Testing effectiveness (Phase 2)Ended earlyNCT01289210
What this trial is testing
VTX-2337 in Combination With Radiotherapy in Patients Low-Grade B-cell Lymphomas
Who this might be right for
Low Grade B Cell Lymphoma
Celgene 2
Showing 20 of 0 results